DGX

Quest Diagnostics
Health Care Services · Health Care · as of 2026-10-05
Last close
$232.22
-0.5% on the session
1-year return
+30.6%
+17.2% over six months
Volatility
24.0%
annualized, trailing year
Max drawdown
-11.6%
worst peak to trough, 1y
What the numbers say

Quest Diagnostics is a health care services name in the health care sector. Over the past year it returned +30.6%, against +9.8% over three months and -3.0% over one. It trades 13.0% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 24.0% is moderate by single-stock standards.

Its worst peak-to-trough decline over the year was -11.6%, and it has traded a median $211M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate -0.07 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Health Care#8 of 59
Stronger than 88% of its sector on the momentum profile
Across the whole index#56 of 496

How DGX scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 4 others in Health Care Services.

Start a free 7-day trial
Full metrics
1 day-0.5%
1 week-2.3%
1 month-3.0%
3 months+9.8%
6 months+17.2%
1 year+30.6%
12-1 momentum+34.6%
Volatility (1y, annualized)24.0%
Max drawdown (1y)-11.6%
Distance vs 200-day average+13.0%
Return per unit of risk1.27
Median daily dollar volume$211M
Free newsletter

Get DGX when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.